Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2025.04.23

NAV

13,612KRW

-15.27하락 (-0.11%)

Market Price per share (KRW)

13,630KRW

-10하락 (-0.07%)

※ t-1 last price

trading volume

166shares

AUM

KRW 6.8billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2025.04.23
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 6,806,150,248
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 13,630
※ t-1 last price 		13,612 166
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
6,806,150,248 하나은행
Market Price per share (KRW) iNAV per share (KRW)
13,630
※ t-1 last price 		13,612
Trading Volume (shares)
166
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2025-04-23
Rank , Name, proportion table
Rank Name Weight (%)
1 Alteogen 12.06
2 SAMSUNG BIOLOGICS 10.90
3 Yuhan 9.56
4 Celltrion 8.66
5 HLB 7.36
6 SKBP 5.51
7 PharmaResearch 4.32
8 SCD 3.78
9 HanmiPharm 2.92
10 원화예금 2.17

proportion by sectors

*The proportion of investment stocks

Update : 2025.04.23
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2025-04-23

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -1.43 -5.91 -12.37 -1.86 14.56 -2.68 34.02
Benchmark Index -1.49 -6.07 -12.79 -2.14 13.20 -2.79 34.50
Outperformance 0.06 0.16 0.41 0.28 1.36 0.1 -0.48

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.04.22 13,630 -0.073하락 13,612.3 -0.112하락
2025.04.21 13,640 -0.146하락 13,627.57 -0.456하락
2025.04.18 13,660 0.183상승 13,690.15 0.523상승
2025.04.17 13,635 1.564상승 13,618.87 1.598상승
2025.04.16 13,425 -0.555하락 13,404.64 -1.054하락
2025.04.15 13,500 -0.037하락 13,547.44 -0.122하락
2025.04.14 13,505 1.047상승 13,564.01 1.370상승
2025.04.11 13,365 1.288상승 13,380.8 1.439상승
2025.04.10 13,195 5.223상승 13,190.9 5.255상승
2025.04.09 12,540 -3.278하락 12,532.27 -3.692하락
2025.04.08 12,965 1.131상승 13,012.81 1.622상승
2025.04.07 12,820 -5.492하락 12,805.04 -5.642하락
2025.04.04 13,565 -0.220하락 13,570.82 -0.527하락
2025.04.03 13,595 1.493상승 13,642.78 1.929상승
2025.04.02 13,395 -1.471하락 13,384.55 -1.802하락
2025.04.01 13,595 2.992상승 13,630.21 3.334상승
2025.03.31 13,200 -2.654하락 13,190.35 -2.647하락
2025.03.28 13,560 -1.632하락 13,549.19 -1.648하락
2025.03.27 13,785 -1.288하락 13,776.3 -1.291하락
2025.03.26 13,965 -0.356하락 13,956.5 -0.335하락
2025.03.25 14,015 0.358상승 14,003.43 0.389상승
2025.03.24 13,965 1.934상승 13,949.15 1.010상승

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Alteogen KR7196170005 211 12.06 82,079,000
2 SAMSUNG BIOLOGICS KR7207940008 69 10.9 74,175,000
3 Yuhan KR7000100008 563 9.56 65,082,800
4 Celltrion KR7068270008 374 8.66 58,942,400
5 HLB KR7028300002 936 7.36 50,076,000
6 SKBP KR7326030004 360 5.51 37,476,000
7 PharmaResearch KR7214450009 82 4.32 29,397,000
8 SCD KR7000250001 184 3.78 25,760,000
9 HanmiPharm KR7128940004 83 2.92 19,878,500
10 원화예금 KRD010010001 14,759,524 2.17 14,759,524
11 CLASSYS KR7214150005 230 2.14 14,559,000
12 SKBS KR7302440003 349 1.98 13,488,850
13 HANALL BIOPHARMA KR7009420001 466 1.9 12,908,200
14 ST Pharm KR7237690003 166 1.86 12,665,800
15 Celltrionph KR7068760008 265 1.83 12,481,500
16 MedyTox KR7086900008 72 1.72 11,728,800
17 SEEGENE KR7096530001 423 1.58 10,723,050
18 CHONGKUNDANG KR7185750007 114 1.31 8,949,000
19 GC Corp KR7006280002 73 1.28 8,723,500
20 CHA Biotech KR7085660009 704 1.17 7,969,280
21 DAEWOONG PHARM KR7069620003 60 1.15 7,794,000
22 Hanmi Science KR7008930000 268 1.11 7,530,800
23 Pharmicell KR7005690003 738 1.08 7,350,480
24 HK inno.N KR7195940002 187 1.03 7,031,200
25 HLBPHARMA KR7047920004 357 1 6,832,980
26 DENTIUM KR7145720009 87 0.95 6,464,100
27 Binex KR7053030003 380 0.91 6,167,400
28 Daewoong KR7003090008 259 0.76 5,141,150
29 BIONEER KR7064550007 293 0.7 4,752,460
30 DongKook Pharm KR7086450004 306 0.69 4,694,040
31 WONTECH KR7336570007 567 0.68 4,643,730
32 EuBio KR7206650004 409 0.67 4,539,900
33 i-SENS KR7099190001 276 0.64 4,333,200
34 SELVAS AI KR7108860008 313 0.64 4,344,440
35 SD Biosensor KR7137310009 471 0.63 4,267,260
36 Boryung KR7003850005 492 0.62 4,226,280
37 T&L KR7340570001 60 0.61 4,158,000
38 BioPlus KR7099430001 524 0.6 4,102,920
39 JWPHARMA KR7001060003 176 0.57 3,872,000
40 Donga ST KR7170900005 64 0.42 2,854,400
41 GC CELL KR7144510005 105 0.33 2,252,250
42 Aprogen KR7007460009 1,971 0.21 1,438,830
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.